Workflow
金发姑娘体制
icon
Search documents
瑞银:美股行情延续,阿尔法机会升温
Zhi Tong Cai Jing· 2025-05-22 04:28
Group 1: Market Trends - After the tariff announcement on April 2, the US stock market quickly priced in a recessionary regime, eliminating the possibility of a "Goldilocks" (moderate growth) scenario. This trend has since reversed, with the probability of the Goldilocks regime returning to March's average level [1] - The Purchasing Managers' Index (PMIs) continues to decline, while OECD leading indicators show the economy remains in a late cycle but has not yet exited the expansion phase. The REVS regime favors late-cycle defensive sectors like communication services, but as leading indicators weaken, preferences may shift more towards utilities [2] Group 2: Earnings Adjustments - Almost all sectors have seen downward revisions in sales and earnings expectations, but the pace of these adjustments has slowed. The sectors with the largest downward revisions include automotive, durable goods, and building materials. The dispersion in earnings scores indicates the presence of alpha opportunities in the market [3] Group 3: Valuation Insights - Forward price-to-earnings ratios have mostly rebounded, returning to a "growth optimism" range. The US stock market's valuation remains higher than other global regions, with dollar-denominated earnings outperforming Europe by 10%, exceeding long-term trends [4] Group 4: Sentiment Analysis - Utilities and consumer staples sectors maintain positive sentiment. UBS crowding data indicates a persistent overweight position in the US market, although it has decreased from March's peak. The significant rotation from cyclical consumer stocks (durable goods and automotive) to defensive sectors (like consumer staples) has not fully normalized [5] Group 5: Top and Bottom Rated Stocks - The highest-rated stocks based on the REVS framework include Intercontinental Exchange, Virtu Financial, and Broadcom, with price changes since March 31 ranging from 10.9% to 37.3% [6] - The lowest-rated stocks include Ziprecruiter, Bioxcel Therapeutics, and Jetblue Airways, with price changes since March 31 ranging from 0% to 3.6% [7]